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RESEARCH ARTICLE
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Abstract
Triggers of the autoimmune response that leads to type 1 diabetes (T1D) remain poorly under-
stood. A possibility is that parallel changes in both T cells and target cells provoke autoimmune
attack. We previously documented greater Ca2+ transients in fibroblasts from T1D subjects
than non-T1D after exposure to fatty acids (FA) and tumor necrosis factor α (TNFα). These
data indicate that metabolic and signal transduction defects present in T1D can be elicited ex
vivo in isolated cells. Changes that precede T1D, including inflammation, may activate atypical
responses in people that are genetically predisposed to T1D. To identify such cellular differ-
ences in T1D, we quantified a panel of metabolic responses in fibroblasts and peripheral blood
cells (PBMCs) from age-matched T1D and non-T1D subjects, as models for non-immune and
immune cells, respectively. Fibroblasts from T1D subjects accumulated more lipid, had higher
LC-CoA levels and converted more FA to CO2, with less mitochondrial proton leak in response
to oleate alone or with TNFα, using the latter as a model of inflammation. T1D-PBMCs con-
tained and also accumulated more lipid following FA exposure. In addition, they formed more
peroxidized lipid than controls following FA exposure. We conclude that both immune and non-
immune cells in T1D subjects differ from controls in terms of responses to FA and TNFα. Our
results suggest a differential sensitivity to inflammatory insults and FA that may precede and
contribute to T1D by priming both immune cells and their targets for autoimmune reactions.
Introduction
Type 1 Diabetes (T1D) is an autoimmune disease with a genetic predisposition that primes the
immune system, mainly T cells, to destroy the insulin-producing β cells of the pancreas. Despite
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the strong evidence for a genetic predisposition towards T1D, epidemiological data indicating
the involvement of additional environmental factor(s) in disease etiology remain compelling.
The human leukocyte antigen (HLA) genotype, the dominant genetic marker for T1D, is found
in only 20–30% of T1D patients, and in only 50% of patients diagnosed in early childhood [1,
2]. In addition, less than half of HLA-susceptible monozygotic twins both develop T1D [3, 4].
Studies that focus on distinct environmental triggers of T1D support a combination of
inflammatory and metabolic changes that associate with disease onset/progression. For exam-
ple, identical twins discordant for T1D show a significant difference in the expression of genes
of arachidonic acid metabolism and TGF-β signaling, two key pathways involved in inflamma-
tion [3, 4]. Specific inflammatory cascades may be critical for T1D onset, as evidenced by data
suggesting that viral infection and the associated inflammation can precede T1D [5, 6], and
exposure of human pancreatic islets to coxsackie virus B5 or inflammatory cytokines increases
the expression of innate immune receptors [7, 8] that may trigger a feed-forward inflammatory
loop. Furthermore, viral infection induces chronic pancreatic inflammation that preferentially
produces CD8-mediated immune responses implicated in β cell destruction [7, 8].
Both environmental cues and genetic predispositions impact expression of cytokines impli-
cated in final stages towards T1D including tumor necrosis factor α (TNFα) [9], a cytokine
activated by multiple viruses and broadly implicated in anti-viral immune responses [10].
Numerous inflammatory cytokines, including TNFα, are produced at higher concentrations
in diabetic subjects compared to controls [11–13]. TNFα is required for β-cell destruction,
likely due to its ability to induce endoplasmic reticulum stress and to promote the accumula-
tion and activation of immune cells in pancreatic β-cells [14–16]. Finally, TNFα deletion in
NOD mice, a strain widely used as a model for T1D, protects against β cell destruction and
associates with the absence of insulin-targeted T-cells [17].
One mechanism by which inflammation may impact cellular metabolism in T1D is through
complex relationships between TNFα and multiple metabolic processes. TNFα inhibits FA
oxidation and stimulates lipolysis in adipocytes [18]. In contrast, TNFα stimulates lipid syn-
thesis and secretion in hepatocytes [19–22]. FA, in turn, have been shown to induce reactive
oxygen species (ROS) production in many cells including PBMCs [23] and endothelial cells,
leading to increased activation of TNFα genes, which have been linked to the production and
release of ROS in fibroblasts in fuel a feed-forward inflammatory loop [24].
Cells share similar pathways of lipid metabolism and cytokine signaling, and we anticipated
that abnormalities in these pathways, if present in T1D patients, would be broadly apparent.
To address the links among inflammation, cellular metabolism and alterations in cellular
responses in T1D, we quantified the metabolic differences between primary human T1D and
non-T1D control cells, using dermal fibroblasts as a model of non-immune cells and PBMCs
as a model of immune cells. We demonstrated that T1D cells differ in cellular metabolism
while resting and while responding to FA (oleate) and cytokines (TNFα) compared to cells
from non-T1D subjects. These findings raise the possibility that T1D etiology is contingent on
metabolic differences that trigger the pathogenic autoimmune response and/or the “attack
me” signal responsible for β cell destruction in genetically susceptible individuals.
Research design and methods
Ethics statement
De-identified human fibroblasts were obtained from The Coriell Institute for Medical
Research (Camden, NJ), under an exempt Institutional Review Board (IRB) protocol. Dermal
fibroblasts were obtained from 5 five normal subjects and five subjects diagnosed with T1D,
and technical replicates of cells were assayed. All 10 donors were white males between the ages
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of 17 and 20 years old. Following informed consent under a Boston University IRB-approved
protocol, human peripheral blood (50–100 mL) was collected from T1D or non-T1D subjects
by venous puncture into acid/citrate/dextrose-containing tubes and cells were processed into
PBMCs as described (Jagannathan-Bogdan et al, 2011 J of Immunol). T1D subjects were
recruited from the Endocrinology, Diabetes and Nutrition Clinic at BMC. Additional T1D
and non-T1D donors were recruited from the Clinical Research Center and the Boston Uni-
versity School of Medicine community. Both human tissues were handled solely by the authors
of this paper in our country of residence.
Cell cultures
Fibroblasts were grown in Minimal Essential Medium (MEM) supplemented with 2X concen-
tration of essential and non-essential amino acids for MEM, 1X MEM vitamin solution, 1X
antibiotic/antimycotic, and 10% fetal bovine serum from Hyclone Laboratories, Inc. All other
cell culture solutions were purchased from Invitrogen. Upon confluence, cells were removed
from culture flasks by incubating for 1 minute in 0.7 mM EDTA in Dulbecco’s phosphate buff-
ered saline (pH 7.4), and then for 2–5 minutes in 0.05% trypsin. Cells were then washed with
phosphate buffered saline/EDTA and used for experiments, or passaged in a ratio appropriate
to the culture’s growth rate. Cells were cultured from passages 3 to 7 (depending on the passage
number of the original stock) to passage 14. No passage-dependent metabolic changes were
observed in any of the cell lines. All experiments were performed in serum free media.
Alternatively, 25 ml of peripheral blood was collected into heparinized tubes by venous
puncture and PBMCs were purified by histopaque 1077. PBMCs were archived in 90% fetal
calf serum/10% DMSO at -80 or liquid nitrogen and analyzed within 3 months, then thawed
and cultured as described [25].
Stimulation conditions
TNFα (Genzyme Corporation, Cambridge, MA) was used at concentrations that approximate
physiological conditions (10 ng/ml: 60 pM, or 25 ng/ml: 150 pM) as indicated. Cells were pre-
incubated with TNFα in serum-free medium for 24 hr prior to the indicated analyses. Cells
treated with FFAs were additionally/alternatively incubated for 24 hrs in oleic acid complexed to
bovine serum albumin (BSA) at a molar ratio of 3:1 and a concentration of 2 mM. For assays that
cannot be completed in the presence of BSA for technical reasons, cells were treated with oleate
(25 or 50 μM) complexed to the alternate delivery molecule cyclodextrin [26] in a 1:6 molar ratio.
Lipid accumulation
Fibroblasts were plated in 48-well plates at the indicated densities then stimulated with 2 mM
oleate prior to staining with Nile Red (1 μg/ml). PBMCs were plated on poly-D-lysine (PDL)
coated 6-well plates at a concentration of 106 cells per well and stained with Nile Red. Cells
were photographed using a Nikon Eclipsed TE200 (Melville, New York) and analyzed on a
Tecan Microplate Reader (Männedorf, Switzerland) at excitation/emission wavelengths of
489/560 nm. Data were normalized on a per cell basis and expressed as a percentage of the val-
ues for unstimulated cells.
Long-chain acyl-CoA (LC-CoA)
Fibroblasts were plated at 7 X 105 cells per well in a 12-well plate and incubated with or with-
out oleate. The following day, cells were washed with modified Krebs buffer, incubated in a 1%
trichloroacetic acid solution containing 3.75 mM DL-dithiothreitol (DTT) for 10 minutes,
Type 1 diabetes alters cellular metabolism
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then precipitates were washed with water. Precipitates were hydrolyzed for 10 minutes in
300 μL of 3.75 mM potassium phosphate buffer (pH = 11.2) to convert LC-CoA to free CoA
and fatty acid. The hydrolysis buffer was neutralized with 2.1 mM TRA-HCl to a pH of 7.4,
and free CoASH was measured enzymatically by utilizing the α-ketoglutarate dehydrogenase
reaction [27]. Standard curves were produced by serial dilution of hydrolyzed long-chain acyl-
CoA (palmitoyl- CoA). NADH luminescence was measured on a Tecan Microplate Reader at
an integration time of 200 milliseconds as described previously [28].
Fatty acid oxidation (FA-oxidation)
Fibroblasts were plated in 24-well plates at a density of 2 X 105 cells per well and exposed to
TNFα for 24 hours. Following TNFα exposure, 14C-oleate oxidation assays for measuring fatty
acid conversion to 14CO2 were performed as previously described [29]. Briefly, cells were incu-
bated in 500 μl/well of modified Krebs buffer containing 3 mM glucose and 12.5 μM 14C-oleate
(54 mCi/mmole, Perkin Elmer). A 1.5 cm round filter paper (Whatman) was suspended above
each well and the plate was sealed for a 2 hr incubation period. At the end of the incubation
period, β-phenylethyl amine was injected onto the filter paper, followed by acidification of the
media with 100 μl/well of 6M sulfuric acid. The cell plate remained sealed for an additional
hour to trap evolved 14CO2 onto the filters. Filter papers were counted in scintillation fluid
(Ecoscint, National Diagnostics) and β particle emission was analyzed using a LabLogic 300SL
Liquid Scintillation Counter (Brandon, Florida). For some studies, FA oxidation was blocked
with etomoxir (30 αm), which inhibits FA activation to LC-CoA by CPT1 and thus, prevents
FA entry into the mitochondria and subsequent oxidation.
NAD(P)H autofluorescence
NAD(P)H fluorescence was determined by exciting at 340 nm and measuring emission at 460 nm
using an Hitachi F-2000 fluorescence spectrophotometer (Hitachi High Technologies Corp.,
Tokyo, Japan). Following trypsinization and washing with PBS/EDTA, approximately 3.5 X 105
cells were suspended in modified Krebs-HEPES buffer containing 2 mM glucose at pH 7.4. Maxi-
mum oxidization of cells was induced by addition of 2.5 μM FCCP, and full reduction by addition
of 10 mM cyanide. Values were expressed as a percentage of maximum reduction.
O2 consumption
O2 consumption was measured using the Seahorse XF24 flux ion analyzer (Boston, Massachu-
setts). Fibroblasts were plated on 24-well Seahorse plates at a density of 1.5 X 105 cells per well.
TNFα was added to some wells 3 hrs after attachment. The plate was then incubated at 37˚C
with 5% CO2 overnight. Media were then aspirated from the plate and cells were incubated in
Krebs buffer containing 15 mM glucose and 10 mM each of glutamine and leucine for 1 hour.
During the measurement phase, four solutions were automatically injected into each well at
indicated times. The first injection (A) was a Krebs solution containing 10 mM glutamine and
10 mM leucine plus oleate (0–50 μM) followed by sequential injections of 10 μM oligomycin-
A (B), 2.5 μM FCCP (C) and 10 μM antimycin-A (D). To account for variation in initial OCR
values among samples, the ratio of each test condition’s OCR was normalized to the control
OCR by calculating a correction factor used to adjust each data point.
Lipid peroxidation (LPO)
LPO was assessed in fibroblasts based on an established protocol [30]. LPO was alternatively
assessed in the PBMCs used in the lipid accumulation experiments (1 million cells per PDL-
Type 1 diabetes alters cellular metabolism
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coated well). Briefly, cells were plated at a density of 3 X 104 cells per well and grown to conflu-
ence in a 48-well plate, then stimulated with oleate and/or TNFα before exposure to a 0.4%
2-thiobarbituric acid/10% acetic acid solution. Sodium hydroxide was added to achieve a final
concentration of 0.0625 N. Standard curves were produced by serial diluting 1,1,3,3-tetra-
ethoxypropane (Sigma, St. Louis, MO). The cell solution was incubated at 90˚C for 60 min,
then cooled and centrifuged at 15,000 g for five minutes. The supernatant was isolated and
fluorescence was measured on the Tecan M1000 plate reader (Männedorf, Switzerland) with
an excitation wavelength of 515 nm and an emission wavelength of 553 nm. Due to variation
[31] among experiments, data were analyzed as a percentage of unstimulated control.
Statistics
Data are presented as the mean and SEM of 6 experiments per condition unless otherwise
specified. Two-way ANOVA with Tukey post-hoc analysis was used to determine significant
differences (p<0.05) among groups [31].
In all figures,  indicates p< 0.05,  indicates p< 0.01,  indicates p<0.001.
Results
T1D cells accumulate more lipid than control cells
Lipid content is an indicator of FA activation and subsequent storage, rather than oxidation.
Although both T1D and control fibroblasts increase lipid content following FA incubation
(Fig 1, compare A to B and C to D), fibroblasts from T1D subjects accumulated more lipid
than fibroblasts from control subjects under both control (Fig 1C vs 1A) and FA-stimulated
conditions (Fig 1D vs 1B), and lipid accumulation was largely independent of plating density
(Fig 1E). In contrast, TNFα did not alter lipid content in either control or T1D fibroblasts
(data not shown). Results from lipid accumulation studies in PBMCs were somewhat different:
lipid levels were similar in PBMCs from control and T1D subjects in the absence of stimula-
tion Fig 2, left panels), and only PBMCs from T1D subjects increased lipid content in response
to FA (Fig 2, right panels). Taken together, these data indicate that lipid storage is higher in
both fibroblasts and immune cells from T1D subjects.
T1D fibroblasts contain more LC-CoA than controls after chronic
exposure to oleate
The first step in cellular metabolism of FA is activation to LC-CoA via long-chain acyl CoA
synthetases. We therefore measured LC-CoA to determine whether the increased T1D lipid
content was associated with increased FA activation in T1D fibroblasts. Fig 3 shows that no
significant difference was observed without added oleate. Oleate exposure led to an insignifi-
cant increase in LC-CoA in non-T1D fibroblasts, but a significant 53% increase in LC-CoA in
fibroblasts from T1D subjects. These data suggest that the greater lipid content in FA-exposed
fibroblasts from T1D subjects was either due to increased lipid synthesis via LC-CoA or
decreased ß-oxidation.
Fibroblasts from T1D subjects converted more FA to CO2 than control
fibroblasts
To determine whether higher LC-CoA levels in FA-exposed cells from T1D subjects (Fig 3)
were due to low FA-oxidizing capacity, causing increased partitioning to stores, we measured
flux of 14C-labeled FA to 14CO2. We further compared control conditions (3 mM glucose) and
high glucose (15 mM) to assess mitochondrial flexibility to use either glucose or FA as
Type 1 diabetes alters cellular metabolism
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Fig 1. Lipid accumulation in human fibroblasts incubated with oleate. Representative images of fibroblasts after staining with Nile Red are shown in
Panels A-D. A and B represent non-T1D fibroblasts with (B) or without (A) stimulation with oleate. Panels C and D represent T1D fibroblasts with (D) and
without (C) FA stimulation. (E) Lipid quantitation by image analysis of the Nile red stain. Human skin fibroblasts from 3 separate non-T1D and T1D patients
were plated at indicated cell densities and stained with Nile Red after incubation with 2 mM oleate complexed to BSA in a 3:1 ratio for 24 hours. Data (E)
are presented as a percent of control (Non-T1D, untreated cells) calculated from a Tecan Microplate Reader.
https://doi.org/10.1371/journal.pone.0188474.g001
Type 1 diabetes alters cellular metabolism
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substrate. At 3 mM glucose, FA oxidation was higher in T1D cells than non-T1D cells (Fig 4A,
left bars). Acute exposure (2.5 hours) to high glucose (15 mM) inhibited FA conversion to
CO2 similarly (21–22%) in both control and T1D fibroblasts (Fig 4A). The positive control, as
Fig 2. Lipid accumulation in human PBMCs incubated with oleate. PBMCs were plated on PDL-coated plates ± oleate (2mM)
complexed to BSA in a 3:1 ratio for 24 hr before being stained with Nile Red. Data are presented as a percent of control (Non-T1D,
untreated cells) calculated from a Tecan Microplate Reader. N = 4.
https://doi.org/10.1371/journal.pone.0188474.g002
Type 1 diabetes alters cellular metabolism
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expected, was markedly inhibited by etomoxir (Fig 4A, right bars). Taken together, these data
showed that T1D fibroblasts oxidized more FA than non-T1D cells, indicating that T1D cells
were not defective in FA oxidation, but rather have both increased lipid synthetic and oxida-
tive capacity.
TNFα inhibits FA conversion to CO2 in fibroblasts
TNFα has been shown to inhibit FA oxidation in other cell types [32]. To determine whether
TNFα impacted FA oxidation in cells from T1D and non-T1D subjects, we incubated cells
with 150 pM TNFα and 3 mM glucose for 24 hr and measured FA oxidation. TNFα treatment
significantly diminished FA oxidation in fibroblasts from T1D subjects, but not from non-
T1D subjects (Fig 4B, left bars). As expected, etomoxir blocked FA oxidation under all condi-
tions tested (Fig 4A and 4B, right bars). We conclude that TNFα eliminated the elevated FA
oxidation characteristic of fibroblasts from T1D subjects.
TNFα induced a more oxidized state in T1D fibroblasts
FA conversion to CO2 causes a more reduced mitochondrial redox state due to production of
NADH during FA β-oxidation [33]. To determine whether the changes in oxidation of FA to
CO2 in the presence and absence of TNFα altered the redox state in human fibroblasts, we
quantified the percentage change of pyridine nucleotide reduction under different incubation
conditions, based on a scale of 100%, from fully reduced with cyanide, to 0%, fully oxidized
Fig 3. LC-CoA content in human fibroblasts. LC-CoA content was determined following culture of fibroblasts ± 2 mM oleate complexed to BSA
in a 3:1 ratio for 18 hours. T1D fibroblasts, on average contained 74 ± 6.5 pmoles/million cells whereas non-T1D fibroblasts contained 49 ± 7.6
pmoles/million cells, following oleate exposure (N = 6).
https://doi.org/10.1371/journal.pone.0188474.g003
Type 1 diabetes alters cellular metabolism
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with the uncoupler, FCCP. Cyanide-mediated reduction was set to 100% reduced, and the
fully oxidized state was determined by exposing the cells to FCCP (0% reduced, 100% oxi-
dized). Fibroblasts from non-T1D subjects were 37% reduced and showed small and
Fig 4. The effect of glucose and TNFα on FA oxidation in human fibroblasts. Non-T1D and T1D fibroblasts were exposed to 14C-labeled
oleate for 2 hours in the presence of either 3 mM or 15 mM glucose (A) or after 24 hr exposure to 1.5 nM TNFα (B) and the conversion of labeled
oleate to 14CO2 during the 2 hr incubation was measured as described in Methods. Etomoxir, an inhibitor of CPT1 and FA oxidation, was used
as a negative control. Data are presented as a percentage of control fibroblast FA oxidation (Non-T1D, untreated cells) (N = 6).
https://doi.org/10.1371/journal.pone.0188474.g004
Type 1 diabetes alters cellular metabolism
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insignificant changes in redox state in response to oleate and TNFα (data not shown). There
was also no signifcant difference between non-T1D and T1D cells under control conditions
(Fig 5, left bar). In contrast, in T1D fibroblasts, incubation with TNFα oxidized the mitochon-
drial redox state by an average of about 40% (Fig 5, second bar) while oleate reduced the redox
state by about 20% (Fig 5, third bar). The redox state in T1D cells treated with a combination
of oleate and TNFα was dominated by the TNFα effect and was more oxidized by about 40%,
consistent with the observed ability of TNFα to inhibit FA oxidation [32] and thus prevent the
production of mitochondrial reducing equivalents during β-oxidation. It should be noted here
that Fig 5 reflects changes in steady state not flux and provides no information about possible
opposing reactions such as utilization of electrons from NADH for oxidative phosphorylation,
proton leak or transhydrogenation.
T1D cells preferentially consume O2 to make ATP with less proton leak
than non T1D cells
To directly compare mitochondrial fluxes in respiration in T1D and control fibroblasts, we
quantified the effects of oleate and/or TNFα exposure on O2 consumption rate (OCR) by cells
from T1D or non-T1D subjects using extracellular flux analysis. To determine efficiencies in
Fig 5. Fibroblasts from T1D subjects reacted to FA and TNFαwith altered cellular redox state. The redox state of fibroblasts was measured
using NAD(P)H autofluorescence after a 24 hr exposure to 2 mM oleate, 0.6 nM TNFα, or both. Data are presented as a percent change from the
control state on a scale ranging from fully oxidized (caused by 2.5 μM FCCP and considered 0% reduced) to fully reduced (caused by 10 mM
cyanide and considered 100% reduced). In non-T1D subjects control percent reduced averaged 38% of maximum. No significant differences were
observed under control conditions between the T1D and non-T1D cells (left bar). The right 3 bars indicate that significant change occurred in
response to FA and TNFα in T1D subjects. No significant changes were occurred in non-T1D fibroblasts in response to TNFα and/or oleate (not
shown) (N = 6).
https://doi.org/10.1371/journal.pone.0188474.g005
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respiration, mitochondrial OCR can be separated into two components: (1) O2 used for ATP
production (oligomycin-sensitive) and (2) mitochondrial proton leak (the difference between
Antimycin A-(fully inhibited) and oligomycin-inhibited respiration) as illustrated in Fig 6A.
Fibroblasts were acutely exposed (18 mins) to oleate complexed to the vehicle (cyclodextrin)
or following 24 hr pre-treatment with TNFα. OCR by fibroblasts did not change in response to
25 μM oleate, but increased in response to 50 μM oleate (Fig 6B). TNFα increased OCR com-
pared to oleate alone in both T1D and non-T1D cells (Fig 6B). Proton leak was induced by ole-
ate in cells from both cohorts, but was significantly lower in fibroblasts from T1D subjects
under all conditions tested (Fig 6C). Lower proton leak in T1D fibroblasts corresponded with
higher ATP production relative to non-T1D cells, in part because ATP production by fibro-
blasts from non-T1D subjects was significantly decreased by oleate and/or TNFα exposure
(Fig 6D). Since total OCR was similar and FA-conversion to CO2 was higher in T1D compared
to control fibroblasts (Fig 4A and 4B), mitochondrial measurements are consistent with the
interpretation that T1D fibroblasts were more efficient in oxidizing lipid with less proton leak,
and thus were able to provide the additional ATP needed to activate and store more FA (Fig 1)
without requiring additional oxygen.
T1D cells contained more peroxidized lipid than controls
Diminished proton leak with higher flux implicates increased production of reactive oxygen
species (ROS) via the electron transport chain. To test this possibility, we assessed peroxidized
lipid, a consequence of ROS production in cells in the presence and/or absence of oleate and/
or TNFα. Control experiments validated that iron (100 μM) increased and deferoxamine
(50 μM) decreased peroxidized lipid, respectively, as expected (Fig 7A, right panels). However,
peroxidized lipid was not significantly increased by oleate and/or TNFα in any of the fibro-
blasts, nevertheless, ANOVA analysis of all pooled conditions showed that fibroblasts from
T1D had more peroxidized lipid than fibroblasts from non-T1D subjects (Fig 7B, 105 ± 4.5
pmol vs. 82 ± 4.5 pmol, p< 0.0005). In contrast, PBMCs from T1D subjects had increased
amounts of peroxidized lipid, regardless of FA treatment, compared to PBMCs from non-T1D
Fig 6. The effect of FA and TNFα on O2 consumption rate (OCR) in human fibroblasts. (A) Illustration of
OCR time course traces of T1D and non-T1D fibroblasts after acute exposure to 50 μM oleate. (B) Total
OCR ± either 25 or 50 μM oleate complexed to cyclodextrin and ± 24 hr exposure to TNFα. (C) The proton
leak was calculated by subtracting the difference between OCR after exposure to antimycin A (totally inhibited
respiration) and oligomycin (ATP generating respiration). (D) OCR used to produce ATP was calculated from
the decrease induced by oligomycin addition (N = 6).
https://doi.org/10.1371/journal.pone.0188474.g006
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subjects (Fig 7C). Oleate treatment further increased peroxidized lipid only in PBMCs from
T1D subjects.
Discussion
Our data provide strong evidence both with fibroblasts and PBMCs to support the conclusion
that cells from T1D subjects handle FA differently from non-T1D cells as regards fat storage,
LC-CoA content, oxidation, and energy efficiency of ATP production. Some differences were
only revealed in the presence of added FAs (documented using oleate) or an inflammatory
mediator (as modeled by TNFα). Additional work is needed to identify the molecular basis for
these differences. Specifically, additional PBMC and fibroblast samples need to be compared
within a closer age range. The average age of the T1D fibroblast donor was 19 years old while
the average age of the PBMC sample donor was 33 years old (S1 Table). This age difference
could be a confounding variable that influenced the overall metabolism of the cells. Additionally,
it is important to differentiate amongst three putative mechanisms to explain the increased
LC-CoA and lipid accumulation in T1D cells: (1) cellular trapping of FA in cytosolic LC-CoA
due to increased expression, activity or localization of acyl-CoA synthetases (ACS), (2) increased
cytosolic acyl CoA or fatty acid binding proteins (FABP) or (3) preferential triglyceride synthesis
Fig 7. Lipid peroxidation in human fibroblasts and PBMCs. The amount of peroxidized lipid (LPO) was measured using the thiobarbituric acid
reaction assay. (A) Comparison of LPO in non-T1D and T1D fibroblasts (N = 7). (B) Scatter graph of all control and T1D values plotted along with
the mean of the pooled data points (horizontal lines) (N = 7). While there was no significance between control and T1D peroxidized lipid under the
individual test conditions in panel A, ANOVA analysis revealed that when all results from panel A were pooled, T1D fibroblasts have a significantly
higher amount of peroxidized lipid than controls. (C) LPO content in PBMCs from non-T1D and T1D patients (N = 4).
https://doi.org/10.1371/journal.pone.0188474.g007
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relative to FA oxidation. Recent evidence has shown that there is a strong correlation between
T1D incidence and up-regulation of FABP-5 [3] that favors triglyceride synthesis [34].
These findings, coupled with our previous work showing differences in Ca2+ mobilization
in T1D compared to non-T1D fibroblasts [35], support the likelihood of metabolic differences
in both non-immune and immune cells in T1D, which may both impact and be impacted by
the virally-induced inflammation that frequently precedes overt T1D [36, 37].
Our data support increased mitochondrial efficiency in T1D that could be either beneficial
or harmful. In many cells, proton leak is hypothesized to be a beneficial adaptive response that
uses the proton gradient to generate the NADPH needed to scavenge ROS and minimize oxi-
dative damage [38–40]. Electrons used to convert NADH to NADPH appear as a leak since the
nicotinamide nucleotide transhydrogenase (NNT), like ATP synthase, uses the mitochondrial
proton gradient as an energy source [41]. The lower proton leak in T1D cells with FA as a fuel
source is associated with greater mitochondrial efficiency since the proton gradient is used for
ATP synthesis rather than for ROS scavenging. Such a reduction in leak could then lead to an
increase in ROS production in T1D cells. Because ROS production requires a high mitochon-
drial membrane potential that is decreased by a proton leak [42–44], the lower proton leak in
T1D cells may explain the higher amounts of peroxidized lipid in PBMCs and fibroblasts from
T1D compared to non-T1D subjects under various conditions.
Based on our results, we propose a model wherein differences in metabolism in cells from
T1D subjects react to exposure to FA by increasing LC-CoA and triglycerides and generate a
more reduced state of the pyridine nucleotides within the cell (Figs 2 and 3). The prevention of
excess ROS through proton leakage in non-T1D cells exposed to FA but not in T1D cells could
underlie differences in ROS and lipid peroxidation (Fig 7).
Overall, our demonstration of metabolic differences in T1D cells sets the stage for the iden-
tification of molecular mechanisms underlying these differences in cellular function and high-
lights a promising new avenue of inquiry into metabolic contributors to T1D that could apply
broadly and inform preventive strategies.
Supporting information
S1 Table. T1D donor treatment information. Information regarding the age, sex and treat-
ment at time of donation of all T1D donors (fibroblasts and PBMCs).
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